Henning Lauterbach

8PUBLICATIONS
14CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)TransgenesisCancer therapy (excl. chemotherapy and radiation therapy)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 28, 2026
Preclinical development of a mutant KRAS targeting therapeutic cancer vaccine.

|Jun 10, 2025
Combining local cytokine delivery and systemic immunization with recombinant artLCMV boosts antitumor efficacy in several preclinical tumor models.

Kimberly Pojar, Diana Reckendorfer, Judith Strauss

|Jul 27, 2024
Arenavirus-Based Vectors Generate Robust SIV Immunity in Non-Human Primates.

Bhawna Sharma, Elena Bekerman, Hoa Truong

|Apr 17, 2024
Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:C.

Celia Gomar, Claudia Augusta Di Trani, Angela Bella

|Apr 17, 2024
Preclinical evaluation of two phylogenetically distant arenavirus vectors for the development of novel immunotherapeutic combination strategies for cancer treatment.

Josipa Raguz, Catarina Pinto, Theresa Pölzlbauer

|Nov 09, 2023
Immunogenic arenavirus vector SIV vaccine reduces setpoint viral load in SIV-challenged rhesus monkeys.

Archana V Boopathy, Bhawna Sharma, Anurag Nekkalapudi

Pageof 2

Frequent Collaborators

3 joint publications

Josipa Raguz

3 joint publications

Pedro Berraondo

2 joint publications

Catarina Pinto

1 joint publications

Hubertus Hochrein